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Abstract: In synaptosomal membranes from rat and mon- 
key brain cortex, the addition of petroselenic (1 8: 1, &A6) 
acid, oleic (1 8: I ,  &A9) acid, and vaccenic ( 1  8: I ,  cis-A”) 
acid or their corresponding methyl esters at 0.5 pmol/mg of 
membrane protein caused a similar 7-10% decrease in the 
microviscosity of the membrane core, whereas at the mem- 
brane surface the microviscosity was reduced 5-7% by the 
fatty acids but only 1% by their methyl esters. Concomi- 
tantly, the fatty acids, but not the methyl esters, inhibited 
the specific binding of the tritiated p-, 6-, and K-opioids Tyr- 
D-Ala-Gly-(Me)Phe-Gly-ol (DAMGO), [ ~ P e n ~ , ~ P e n ’ ] -  
enkephalin (DPDPE), and U69,593, respectively. As shown 
with oleic acid, the sensitivity of opioid receptor binding 
toward inhibition by fatty acids was in the order 6 > p + K, 
whereby the binding of [3H]DPDPE was abolished, but sig- 
nificant inhibition of [3H]U69,593 binding, determined in 
membranes from monkey brain, required membrane modi- 
fication with a twofold higher fatty acid concentration. Ex- 
cept for the unchanged KD of [3H]U69,S93, the inhibition 
The role of membrane environment in modulating 
the activity ofintrinsic menbraze proteins is well CGC- 
umented. Specifically, in numerous studies the func- 
tion of membrane-bound enzymes, receptors, and 
transport camers was correlated with membrane fluid- 
ity, a biophysical property largely determined by 
membrane composition at a given temperature (Aloia 
et al., 1988; Viret et al., 1990). The results of these 
studies have confirmed the significance of membrane 
fluidity as a parameter that affects the dynamics and 
thereby the biological activity of various membrane 
constituents. However, it has also been shown that 
modulation of membrane protein function may oc- 
cur by the interaction of the proteins with distinct 
membrane lipids rather than as the result of an altered 
by oleic acid involved both the B,, and affinity of opioid 
binding. Cholesteryl hemisuccinate (0.5-3 pmol/mg of pro- 
tein), added to membranes previously modified by fatty 
acids, reversed the fluidization caused by the latter com- 
pounds and restored inhibited p-, 6, and rt-opioid binding 
toward control values. In particular, the B,, of [3H]- 
DPDPE binding completely recovered after being undetect- 
able. The results implicate membrane surface fluidity in the 
modulation of opioid receptor binding, reveal distinct sensi- 
tivity of 6, p, and u receptors toward that modulation, and 
identify unsaturated fatty acids and cholesterol as possible 
endogenous regulators of opioid receptor function. Key 
Words: p-, 6-, and u-opioid reeeptors-Fatty acids-Choles- 
terol-Membrane fluidity-Synaptosomal membranes- 
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bulk property of the lipid bilayer (Carruthers and 
Mekhioi, 1986). The existeilce of opioid receptors in 
different membrane microenvironments was pro- 
posed (Maruyama et al., 1987), and the clustering of 
opioid receptors on cell surfaces, presumably as the 
result of lateral mobility in the membrane, has been 
described (Hazum et al., 1980). Although it was not 
measured, increased membrane fluidity was dis- 
cussed as a phcnornenon underlying the reduction of 
opioid binding in neuroblastoma X glioma cells 
grown in the presence of unsaturated fatty acids (Ho 
and Cox, 1982). On the other hand, the presence of 
specific lipids, rather than altered membrane fluidity, 
was postulated as a requirement for opioid receptor 
coupling to adenylate cyclase in rat brain membranes 
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(Childers and LaRiviere, 1984). Altered binding of 
tritiated enkephalinamide binding in brain mem- 
branes of differing fluidity was first reported by Heron 
et al. ( 198 I ), and the sensitivity of the opioid receptor 
to effects of fatty acids was described earlier (Lin and 
Simon, 1978; McGee and Kenimer, 1982). 
Recently we have shown that, at comparable mem- 
brane content, the cis isomers of monounsaturated 
fatty acids were more potent than their trans counter- 
parts in inhibiting opioid binding and in increasing 
thc fluidity of rat brain mcmbranes (Remmers et al., 
1990). Considering the results of that research and the 
proposed localization of the 6-, p-, and K-opioid recep- 
tors in membrane regions of different hydrophobicity 
and charge (Schwyzer, 1986; Schiller et al., 1989), the 
aim of the present study was to examine the mecha- 
nism underlying the potent effects of fatty acids on 
opioid binding, focusing thereby on the role of mem- 
brane domains and their fluidity. A brief account of 
this work was presented previously (Lazar et al., 
1Y91). 
MATERIALS AND METHODS 
iMaterials 
[311]Tyr-r).Ala-Gly-(Me)Phe-Gly-ol ( [3H]DAMGO) and 
[3H](~-Pen2,~Pen5)enkephalin ([3H]DPDPE) were pur- 
chased from Amersham (Arlington Heights, IL, U.S.A.), 
whereas [-'H]U69,593 was obtained from New England Nu- 
clear (Boston, MA, U.S.A.). All unlabeled opioids were sup 
plied by the Narcotic Drug and Opiate Peptide Basic Re- 
search Center at The University of Michigan. l h e  fatty 
acids (FA) petroselenic (cis-A6-octadecenoic). oleic (cis-A9- 
octadecenoic), and vaceenic (cis-A"-octadecenoic), and 
their methyl esters were obtained from Serdary Ldborato- 
ries (London, Ontario, Canada). Cholesteryl hemisuccinate 
(CHS) and other biochemicals were purchased from Sigma 
Chemical (St. Louis, MO, U.S.A.). Diphenylhexatriene 
(DPH), trimethylammonium-DPH (TMA-DP€I), and 
propionic acid-DPH (PA-DPII) were obtained from Molec- 
ular Probes (Junction City, OR, U.S.A.). 
Membrane preparation 
The synaptosomal preparation was obtained from brain 
cortices of male Sprague-Dawley rats or a rhesus monkey as 
described by Cahill and Medzihradsky (1976) and Clark et 
al. ( 1988). The preparation was thoroughly characterized by 
marker emymes, ion content, and synaptosomal transport 
processes. The contamination by mitochondria was <5%1 
(Cahill and Medzihradsky, 1976). Membranes were isolated 
by hypotonic disruption in 50 m M  Tris-HCI, pH 7.4, using 
a Dounce all-glass homogenizer. The obtained membrane 
suspension, at a protein concentration of approximately 3 
mg/ml, was stored at --80"C. Protein was determined ac- 
cording to Lowry et al. (195 1 )  using bovine serum albumin 
as standard. Prior to the determination, the membranes 
were solubilized with 1 M NaOH for 30 rnin at 25°C. 
Membrane modifications 
FA, fatty acid methyl esters (FAME), or CHS was added 
to membrane suspensions as solutions in ethanol. Meni- 
branes were then incubated at 25°C for either 20 rnin (addi- 
tion of FA or FAME) or 30 rnin (addition of CHS). In con- 
trol experiments, membranes were incubated with ethanol 
alone. In experiments where the final ethanol concentration 
exceeded 0.5%, the membranes were centrifuged for 15 min 
at 22,500 g and then resuspended in 50 m M  Tris-HC1, 
pH 1.4. 
Measurement of membrane microviscosity 
The fluorcscent probe DPH (solution in tetrahydrofuran) 
and its cationic and anionic derivatives TMA-DPH and 
PA-DPH (solutions in N,N-dimethylforrnamide), respec- 
tively, were incubated with membranes at 25°C. Fluores- 
cence measurements were made with an SLM 8000 spectro- 
fluorometer using excitation and emission wavelengths of 
340 nm and 450 nm, respectively. The results were ex- 
pressed as anisotropy values ( I )  where r = (I, - IW)/(I, 
- Z9,) and I ,  and Z9, represent the intensities of light when 
polarizers were in a parallel or perpendicular orientation, 
respectively. The advantage of expressing fluorescence po- 
larization as anisotropy is the additive nature of the latter. 
Differences in the efficiency of transmitting vertically and 
horizontally polarized light were corrected for by the factor 
lollw, determined by using horizontally rather than verti- 
cally polarized excitation light. 
Varying the molar ratio of membrane phospholipid to 
probe from 500: 1 to 100: 1 did not affcct the measured an- 
isotropy values, indicating the absence of membrane pertur- 
bations by the probes. Anisotropy values were also unal- 
tered by different amounts of membrane protein, ranging 
from 35 pg to 100 pg in a final volume of 2 ml of 50 mM 
Tris-HC1, pH 7.4. Furthermore, anisotropy measurements 
in both control and modified membranes were stable from 
30 rnin to 3 h after the addition of the probe. Therefore, 
membrane microviscosity was determined with a molar ra- 
tio of membrane phospholipid to probe of 200: 1 and with 
50 pg of membrane protein per tube after 60 rnin of incuba- 
tion at 25°C. 
Ligand binding 
The equilibrium binding of radiolabcled opioids at 25°C 
was determined as previously described by Fischel and 
Medzihradsky (1981). The assay medium contained 150- 
200 pg of membrane protein per tube. In experiments with 
[3H]IJ69,593, the glass-fiber filters were pretreated with a 
0.05% aqueous solution of polyethyleneimine, pH 7.4, to 
reduce binding of the radiolabeled opioid to filters (Hamp- 
ton et al., 1982). Specific binding ofthe radiolabeled ligands 
was determined in the absence and presence of an excess of 
the respective unlabeled ligand (2 pM DAMGO, 5 pA4 
DPDPE, 2 rMU69,593). Binding equilibrium was reached 
at 80 min, 60 min, and 40 rnin for radiolabeled DAMGO, 
DPDPE. and U69,593, respectively. 
Data analysis 
The results on ligand binding were analyzed by the statis- 
tical program SYSTAT (Wilkinson, 1988) considering mod- 
els of one and two binding sites (Remmers et al., 1990). The 
regression analysis was canied out with data from three to 
five replicate experiments. All the binding parameters 
shown in Table 1 are based on regression for which the 
distribution of residuals was not different from a normal 
distribution. The corresponding SEM values were obtained 
from the residual sum of squares, provided by the regression 
analysis. The data on membrane microviscosity were ana- 
lyzed by the computer program GraphPad (IS1 Software, 
Philadelphia, PA, U.S.A.), and are expressed as mean values 
and SEM. 
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RESULTS 
Initially, the modulation of membrane microviscos- 
ity by three C,8 cis-monounsaturated FA and their 
respective methyl esters (Fig. 1) was investigated. The 
addition of equimolar amounts of FA or FAME to 
membranes from rat cortex caused a similar 7-10% 
decreasc in DPH fluorescence anisotropy, indicating 
a fluidization of the hydrophobic core of the mem- 
brane (Fig. 2). As shown with the charged fluoro- 
phores TMA-DPH and PA-DPH (Fig. l), membrane 
modification by FA decreased microviscosity in the 
surface region of the membrane by 5-770. In contrast, 
following the addition of FAME, the fluidization of 
the membrane surface was only marginal. This dis- 
tinct pattern of fluidization caused by the charged and 
methylated FA, respectively, was similar regardless of 
the position of unsaturation in the molecule (Fig. 2). 
Furthermore, in membranes from monkey brain cor- 
tcx, oleic acid and methyl oleate decreased microvis- 
cosity at the core and surface regions of the mem- 
brane with a similar pattern and magnitude as that 
observed in membranes from rat cortex (data not 
shown). Actually, methyl oleate was even more po- 
tent in fluidizing the core region of monkey rather 
than rat membranes (14% and 9% decreasc in anisot- 
ropy, respectively). 
The reduction of membrane microviscosity by FA, 
both in the core and surface region of the membrane, 
was completely reversed following the addition of 
CHS. CHS was particularly effective in restoring the 
microviscosity of membranes initially fluidized by FA 
(Fig. 3). Once the normal level of microviscosity at the 
membrane surface was restored, further rigidification 
progressed at a slower rate, and in control membranes 
low concentrations of CHS had no effect. In contrast, 
CHS strongly increased the microviscosity in the core 
of both FA-treated and control membranes (Fig. 3). 
MEMBRANE MODIFIERS 
In the modified membranes, ligand binding to 
opioid receptors was inhibited in strict correlation 
with the degree of achieved fluidization at the mem- 
brane surface. Accordingly, opioid binding was 
largely unaffected in membranes treated with FAME. 
On the other hand, the unsaturated FA inhibited 
opioid binding by a distinct pattern of b > p % K ,  
whereby the 6 receptor, and to a lesser extent, the p 
receptor, exhibited increasing sensitivity as the posi- 
tion of the double bond approached the carboxyl end 
of the molecule (Fig. 5). These results, obtained 
with one receptor-saturating concentration of radioli- 
gand, were confirmed by Scatchard analysis of opioid 
binding: free oleic acid at 0.5 pmol/mg of protein ren- 
dered the B,,, of 6 receptor binding undetectable, and 
considerably inhibited ligand interaction with the p 
receptor (Fig. 6 and Table 1). On the other hand, in 
monkey brain membranes used to significantly mea- 
sure K-Opioid binding, the concentration of oleic acid 
had to be raised twofold relative to that modulating 6 
and p binding. But even at that concentration, only 
the B,,, but not K,, of r3H]U69,593 binding was 
affected. Furthermore, equimolar concentrations of 
elaidic acid, the trans isomer of oleic acid with dimin- 
ished fluidizing properties (Remmers et al., 1990 and 
Fig. 4) was only marginally effective (Table 1). Methyl 
oleate did not significantly affect the parameters of 
ligand binding to any of the opioid receptors. Con- 
sidering the low levcl binding of [3H]U69,593 in rat 
brain (Clark et al., 1988), all experiments pertaining 
to the K opioid receptor were carried out in mem- 
branes from monkey brain cortex. It was ascertained 
that in these membranes the pattern of fluidization 
(Fig. 4) and inhibition of 8-, p-, and K-opioid binding 
by FA (Figs. 5 and 6) was similar to that observed in 
membranes from rat brain. 
In addition to restoring the reduced membrane mi- 
croviscosity caused by oleic acid (Figs. 3 and 4), the 
MEMBRANE FLUIDITY PROBES 
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subsequent addition of CHS reversed the inhibition of 
ligand binding by approximately 40 fmol/mg of pro- 
tein at the p and K receptors, and by 90 fmol/mg of 
protein at the hpio id  receptor at which binding was 
initially abolished by treatment with FA alone (Fig. 6 
and Table 1). After CHS treatment only the K,, of 
[3H]DPDPE remained higher relative to the control 
value (Table 1). In untreated membranes the addition 
of CHS increased the B,,, of 6-, p-, and K-OpiOidS, by 
38%, 25%, and 23%, respectively. In these mem- 
branes, as in those treated with FA, the KD at the 6 site 
was affected most (Table 1). 
DISCUSSION 
Using fluorescent probes to assess regional fluidiza- 
tion in brain membranes, the results of the present 
study implicate the microviscosity at the membrane 
surface in the modulation of opioid receptors. The 
inhibition of receptor binding by free and methylated 
FA was proportional to the ability of these com- 
pounds to decrease the microviscosity at the brain 
membrane surface. The inhibition at the 6 and, to a 
lesser extent, p receptor by FA increased as the posi- 
tion of the cis-unsaturated bond, a structural feature 
with strong fluidizing properties, moved closer to the 
carboxyl end of the molecule. Measurement of mem- 
10 E 
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FIG. 2. Microviscosity of rat-brain membranes modified by FA 
and their methyl esters. Synaptosomal membranes were modi- 
fied by the addiion of 0.5 pmd/mg of membrane protein of either 
petroselenic (cis-A6-octadecenoic) acid: oleic (cis-A'atadece- 
noic) acid; or cis-vaccenic (cis-A"atadecenoic) acid (Q, or their 
corresponding methyl esters (0). After the incorporation of DPH 
(A), TMA-DPH (B), or PA-DPH (C) into control or modified mem- 
branes. fluorescence anisotropy was determined as described in 
Materials and Methods. Shown are the means and SEM of three 
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FIG. 3. Microviscosity of rat brain membranes modified by cho- 
lesterol. Control synaptosomal membranes (0) and membranes 
initially treated with 0.5 pmd/mg of membrane protein of oleic 
acid (0) were modified by the addition of increasing concentra- 
tions of CHS as shown. Following incorporation of DPH (A), 
TMA-DPH (B), or PA-DPH (C), fluorescence anisotropy (r) was 
determined as described in Materials and Methods. Shown are 
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FIG. 4. Microviscosity of monkey brain membranes. Cortical 
membranes were modified by the addition of 1 pmol/mg of mem- 
brane protein of oleic acid (OA), methyl oleate (MO), elaidic acid 
(EA), or oleic acid followed by 3 pmollmg of membrane protein of 
CHS (O/C). After the incorporation of DPH (A) or TMA-DPH (B) 
into control or modified membranes, fluorescence anisotropy was 
determined as described in Materials and Methods. Shown are 
the means and SEM of three experiments. each canied out in 
triplicate. 
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FIG. 5. Pattern of inhibition of opioid receptor binding following 
membrane modification. Synaptosomal membranes from rat 
brain were incubated with 0.5 pmollmg of membrane protein of 
either petroselenic (cis-As-octadecenoic) acid; oleic (cis-A9-octa- 
decenoic) acid, or vaccenic (cis-A"-octadecenoic) acid (O), or 
their corresponding methyl esters (0). Subsequently, the specific 
binding of r3H]DPDPE (A), [3H]DAMG0 (B), or [3H]U69,593 (C) 
was determined at a fixed ligand concentration of 10-fold the 
respective KD value in untreated membranes. In identically modii 
fied membranes from monkey brain, the specific binding of tri- 
tiated DPDPE, DAMGO, and U69,593 was inhibited (in percent) 
75.9?2.6,47.0+ 1.5.and15.3+_0.3.Shownarethemeaosand 
SEM of at least three experiments, each carried out in triplicate. 
brane microviscosity with various probes has shown 
that the surface region of both natural (Viret and Le- 
terrier, 1976) and synthetic (Chefurka et al., 1987) 
membrane bilayers is more rigid than the hydropho- 
bic core region. As such, the membrane surface region 
is expected to havc a more constraining effect on the 
positioning and conformation of receptors within the 
bilayer than the more fluid core. The negatively 
charged carboxyl group of free FA interacts by hydro- 
gen bonding with the polar phospholipid headgroups 
(Ortiz and Gomez-Fernandez, 1987). Thus, fluidiza- 
tion of the membrane surface region by FA is likely to 
perturb some of the lipid headgroup-protein interac- 
tions required for the function of membrane proteins 
(Marsh, 1987). In contrast, fluidization of the mem- 
brane core by FAME may leave these interactions in- 
tact. 
The 6-opioid receptor was most sensitive to inhibi- 
tion by FA membrane treatment with oleic acid abol- 
ished [3H]DPDPE binding, reduced the affinity and 
B,, of [3H]DAMG0, but significant effects at the K 
receptor required higher concentration of the FA. 
Still, the involvement of membrane fluidity in the in- 
hibition of K receptor function by oleic acid was un- 
derlined by the attenuated effect of its trans enan- 
tiomer, elaidic acid (Table 1).  Trans FA were previ- 
ously shown to have a much smaller effect on 
membrane fluidization than their cis counterparts 
(Remmers et al., 1990). A similar pattern of opioid 
receptor sensitivity to membrane perturbation has 
previously been demonstrated: ethanol inhibited 
opioid receptor binding with a rank order of 6 2 p 9 K 
(Hiller et al., 1983; Khatami et al., 1987). Although in 
these studies membrane microviscosity was not deter- 
mined, an altered microenvironment of the receptor 
was implicated. Significant evidence for a role of 
membrane fluidity in the modulation of opioid recep- 
tors was provided by the ability of CHS to reverse 
"0 40 90 120 
['HIDPOPE BWNO i f n o l h g  p r o t e i n ]  
[%]DAMGO BWND l fnol /ng  p r o t e i n ]  
0 30 60 w 
[3HlU69. 593 BOUND i fnol /ng  p r o t e i n )  
FIG. 6. Scatchard plots of opioid binding in modiied brain mem- 
branes. Equilibrium binding of [%]DPDPE (A), [3H]DAMG0 (B), 
and [3H]U69,593 (C) was determined in control membranes (0), 
and membranes modified with 0.5 pmol/mg of membrane protein 
(rat brain, A and B) or 1 pmol/mg of membrane protein (monkey 
brain, C) of olelc acid (0) or methyl oleate (m), or with oleic acid (as 
above) followed by 3 pmollrng of protein of cholesteryl hemisuc- 
cinate (A). Shown are data points from a representative experi- 
ment. The binding parameters K, and 6, were obtained by 
nonlinear regression analysis from data obtained in three 
experiments. The corresponding mean values and statistical in- 
formation are listed in Table 1. 
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TABLE 1. Parameters of opioid binding in modffied and control bruin membranes 
Modifiers 
added 
Amount added KD &I., 
(pmol/mg of protein) (nM) (fmol/mg of protein) n 

















Binding of ['HJDAMGO 






























97.7 (8. I )  
ND 
90.0 (17.0) 





























The binding parameters at equilibrium were obtained from nonlinear regression analysis, fitting the data to a one-site model for ligand 
binding. Shown are parameter means and SEM values (in parentheses) computed from the total number of data points (n) obtained in three 
experiments depicted in Fig. 6. Membrane modification was carried out as described in Materials and Methods. OA, oleic acid; MO, methyl 
oleate; CHS, cholesteryl hemisuccinate; EA, elaidic acid. ND, not detectable. 
both consequences of FA modification of brain mem- 
branes: decreased microviscosity and inhibition of li- 
gand binding. The effect of CHS at the 6 receptor was 
particularly striking: after being abolished in the fluid- 
ized membranes, [3H]DPDPE binding was restored to 
control levels following CHS treatment. The elevated 
KD of 6- but not p- or K-opioid binding in CHS-treated 
membranes (Table 1) could reflect interference with 
ligand binding by the interaction of this negatively 
charged modifier with the cationic environment of 
the 6 receptor (Schwyzer, 1986; Sargent et al., 1988). 
Furthermore, the proposal that the 6 and p sites reside 
in a cationic and anionic microenvironment, respec- 
tively, could explain the preferential targeting of the 6 
receptor by the negatively charged FA. 
Lateral and vertical heterogeneity within a given 
membrane with respect to lipid composition, protein 
distribution, and physicochemical state contribute to 
the existence of membrane domains with different 
characteristics (Melchior, 1986; Treistman et al., 
1987). Furthermore, specific interactions between 
membrane proteins and certain membrane lipids (La- 
truffe et al., 1986; Marsh, 1987) define a specific lipid 
boundary layer around functional membrane pro- 
teins such as the nicotinic acetylcholine receptor 
(Jones et al., 1988). Attempts to reconstitute ligand 
binding to the partially purified p- (Hasegawa et al., 
1987) and 6- (Scheideler and Zukin, 1990) opioid re- 
ceptors have indicated requirements for specific phos- 
pholipids. It is reasonable, therefore, to consider the 
existence of different local domains or boundary 
layers for the distinct types of opioid receptors in 
brain membranes. Interestingly, both ethanol (Wood 
et al., 1989) and cis-unsaturated fatty acids (Klausner 
et al., 1980; Ortiz and Gomez-Fernandez, 1987) have 
greater fluidizing effects on fluid-like regions than gel- 
like regions when added to membrane preparations. 
Considering the similar effects of these two fluidizers 
on opioid receptor binding, the lipid domains in 
which p and 6 receptors reside may be more fluid than 
those in which K receptors exist. Notably, studies with 
bivalent ligands have indicated a physical complex 
between some p and 6 receptors (Schoffelmeer et al., 
1990). Although ethanol was reported to have order- 
ing effects on neuronal membranes at very low con- 
centrations and elevated temperatures (Hitzemann et 
al., 1986) or following chronic administration (Hams 
et al., 1984), acutely and under the experimental con- 
ditions of the present study ethanol fluidized the 
membrane surface (Harris et al., 1984; Harris and 
Bruno, 1985). 
Changes in lipid composition and membrane fluid- 
ity were shown to affect the function of membrane 
proteins by affecting their conformational states 
(Fong and McNamee, 1987; Aloia et al., 1988). For 
example, membrane fluidization by either unsatu- 
rated FA or ethanol inhibited the transition to 
the K+-sensitive conformation of Na+,K+-ATPase 
(Swann, 1984), and a decrease in membrane fluidity 
elicited conformational changes in the lipid-buried 
subunit of mitochondria1 H+-ATPase that were trans- 
mitted to the aqueous subunit of the enzyme (Zhang 
and Yang, 1989). Thus, the effects of FA and choles- 
terol described in the present study could reflect the 
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distortion and restoration, respectively, of opioid re- 
ceptor conformation that is optimal for ligand bind- 
ing. Furthermore, according to this concept, the 
strong inhibition of opioid receptor binding by a high 
concentration of cholesterol, observed previously 
(Heron et al., 198 l), can be the consequence of dis- 
placement by the sterol of essential lipids in the bound- 
ary layer surrounding the receptor. 
The seemingly high concentration of CHS required 
to maximally reverse inhibition of opioid binding by 
cis-monounsaturated FA is likely to be due to a short- 
coming of the applied methodology: the measure- 
ment of membrane microviscosity with probes such 
as DPH, TMA-DPH, and PA-DPH does not neces- 
sarily reflect fluidity changes occurring in the mi- 
croenvironment of the opioid receptors. Although 
bulk membrane fluidity could have returned to con- 
trol levels, the fluidity sensed by the opioid receptors 
may still be greater than that in control membranes. 
At higher levels of cholesterol, whose compartmenta- 
lization in membranes was described (Leibel et al., 
1987), its concentration in various membrane do- 
mains will increase, thus reversing fluidity in the lipid 
boundary layer of the receptors and, concomitantly, 
restoring opioid binding. Further studies with mem- 
brane modification (Medzihradsky, 1989) will be 
needed to specifically alter the composition and physi- 
cochemical property of the boundary layer, the lipid- 
protein interface that is likely to have a strong effect 
on the conformation and function of opioid recep- 
tors. 
Numerous physiological conditions have been 
shown to modulate the lipid composition and fluid- 
ity of biological membranes. These include diet 
(McMurchie, 1988), development (Hitzemann and 
Hams, 1984), and aging (Shinitzky, 1987). In addi- 
tion, drug administration (Heron et al., 1982) and 
various pathological conditions have resulted in al- 
tered Zembrane content, of !ipids m d  cholesterol 
(e.g., Aloia and Boggs, 1985). For example, in experi- 
mentally induced cerebral ischemia (Yoshida et al., 
1983) significant increases in the concentration of free 
FA in brain were described. Therefore, the ability of 
FA and cholcsterol to alter membrane microviscosity 
and differentially affect ligand binding to the 6, 1.1-, 
and K-opioid receptors may have significant implica- 
tions for the modulation of opioid action in vivo. 
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